Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PHASEAL

K-Number: K023747 · 2002-11-15

Decision Date2002-11-15
Product CodeLHI
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

PHASEAL is the device name listed in this FDA 510(k) record. The listed applicant is Carmel Pharma Ab.. It received FDA 510(k) clearance on 2002-11-15 under 510(k) number K023747. The device is classified under product code LHI. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PHASEAL?

PHASEAL is a medical device that received FDA 510(k) clearance on 2002-11-15. The listed applicant is Carmel Pharma Ab.. The 510(k) number is K023747.

When did PHASEAL receive FDA 510(k) clearance?

PHASEAL received FDA 510(k) clearance on 2002-11-15, under 510(k) number K023747.

Who is the listed applicant for PHASEAL?

The FDA 510(k) record lists Carmel Pharma Ab. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for PHASEAL?

The FDA product code for PHASEAL is LHI.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Carmel Pharma Ab. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 7 devices →

Related Devices (Code: LHI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑